BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021

Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS) announced it will release its third quarter 2021 financial results after market close on November 11, 2021. Following the release, a conference call is scheduled for 4:30 PM ET where management will discuss the financial results and provide a business update. Investors can access the call through the company’s Investor Relations page or via phone. BioLife is a leading supplier of bioproduction tools and services for the cell and gene therapy market.

Positive

• Upcoming conference call for detailed financial insights on November 11, 2021.

Negative

• None.

BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2021 financial results will be released after market close on Thursday, November 11^th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day.  Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. Alternatively, you may access the live conference call by dialing 1 (844) 825-0512 or international callers at 1 (315) 625-6880 with the following Conference ID: 7075159. A webcast replay will be available approximately two hours after the call and will be archived on https://www.biolifesolutions.com/ for 90 days.

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary CryoStor^® and HypoThermosol^Ò biopreservation media for shipping and storage, the ThawSTAR^® family of automated, water-free thawing products, evo^® cold chain management system,  Custom Biogenic Systems high capacity storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

Contact

Roderick de Greef
Chief Financial Officer
(425) 686-6002
rdegreef@biolifesolutions.com

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-third-quarter-2021-financial-results-and-provide-business-update-on-november-11-2021-301416475.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions release its Q3 2021 financial results?

BioLife Solutions will release its Q3 2021 financial results after market close on November 11, 2021.

How can I listen to BioLife Solutions' earnings call?

You can listen to BioLife Solutions' earnings call by visiting their Investor Relations page or by dialing 1 (844) 825-0512 with Conference ID: 7075159.

What time is the BioLife Solutions Q3 2021 earnings call?

The earnings call is scheduled for 4:30 PM ET on November 11, 2021.

What is BioLife Solutions known for?

BioLife Solutions is recognized as a leading supplier of bioproduction tools and services for cell and gene therapies.